ClinicalTrials.gg
Sign In
BiologicalCombination product

Mva-bn-brachyury-tricom vaccine clinical trials

Also written MVA-BN-Brachyury.

studies test it
3
open now
0
in phase 3
0
first study started
2018

How each study uses mva-bn-brachyury-tricom vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Other names

MVA-BN-Brachyury
2

Studies by the year they started

3 studies that test it; most in 2018 (1)

Studies that test mva-bn-brachyury-tricom vaccine, by start year
YearStudies
20181
20191
20201

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
1

Who runs them

Industry 2 · Other 1

Bavarian Nordic (2) · University of Utah (1)

Often tested with

Tested in the same studies.

FPV-Brachyury-TRICOM Vaccine (1)

Studies

Open first, then newest update. How each study uses mva-bn-brachyury-tricom vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Given beside what is tested · 1 — mva-bn-brachyury-tricom vaccine is usual care or a partner of the new treatment

Codes

What other systems call mva-bn-brachyury-tricom vaccine · ClinicalTrials.gg INT016660

  • UNII (FDA) GD1ZWN2I2YMVA-BN-BRACHYURY-TRICOM VACCINEOne source FDA
  • NCI Thesaurus C148400MVA-BN-Brachyury-TRICOM VaccineOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.